Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma()()

Advanced-stage cutaneous T-cell lymphoma (CTCL) is usually a fatal malignancy despite optimal use of currently available treatments. In this preclinical study of novel CTCL therapy, we performed in vitro and ex vivo experiments to determine the efficacy of combination treatment with a panel of BET b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lei, Okhovat, Jean-Phillip, Hong, Eric K., Kim, Youn H., Wood, Gary S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280696/
https://www.ncbi.nlm.nih.gov/pubmed/30529073
http://dx.doi.org/10.1016/j.neo.2018.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280696/
https://www.ncbi.nlm.nih.gov/pubmed/30529073
http://dx.doi.org/10.1016/j.neo.2018.11.006

Ejemplares similares